Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
1.075
-0.025 (-2.27%)
Apr 16, 2026, 12:31 PM EDT - Market open
Oncolytics Biotech Stock Forecast
Stock Price Forecast
The 3 analysts that cover Oncolytics Biotech stock have a consensus rating of "Strong Buy" and an average price target of $7.33, which forecasts a 581.86% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $10.
Price Target: $7.33 (+581.86%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 17, 2025.
Analyst Ratings
The average analyst rating for Oncolytics Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +830.23% | Nov 17, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +551.16% | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +365.12% | May 21, 2025 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 16, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $5 → $3 | Strong Buy | Maintains | $5 → $3 | +179.07% | Mar 10, 2025 |
Financial Forecast
Revenue This Year
2.02M
Revenue Next Year
52.62M
from 2.02M
Increased by 2,505.00%
EPS This Year
-0.35
from -0.30
EPS Next Year
-0.27
from -0.35
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.3M | 109.4M | |||
| Avg | 2.0M | 52.6M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 5,316.3% | |||
| Avg | - | 2,505.0% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.29 | -0.13 |
| Avg | -0.35 | -0.27 |
| Low | -0.38 | -0.41 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.